Correction to: efficacy and safety of the switch of Triumeq ® to generic (abacavir + lamivudine) + Tivicay®: data at 24 weeks
Source: BMC Clinical Pharmacology - Category: Drugs & Pharmacology Authors: Juli án Olalla, Javier Pérez-Stachowski, Begoña Tortajada, Alfonso Del Arco, Efrén Márquez, Javier De la Torre, Miriam Nieto, José María García de Lomas, José Luis Prada and Javier García-Alegría Tags: Correction Source Type: research
More News: Drugs & Pharmacology